Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
GENPACT LTD

G

GENPACT LTD

GENPACT LTD historical holders

total: 7

Causeway Capital Management GENPACT LTD transactions over time

Total transactions:
24
New positions:
1
Added:
12
Reduced:
11
Held since:
2020 Q2
Held for:
24 quarters
Latest activity:
2026 Q1
Sarah Ketterer has been an institutional investor in GENPACT LTD (G) since 2020 Q2. According to 2026 Q1 report, Sarah Ketterer holds 1,948,677 shares with a market value of roughly $72.59M representing 0.89% of their equity portfolio. The fund/company first acquired G in 2020 Q2, initially purchasing about 1.20M shares. Since the initial investment, Causeway Capital Management has made 23 more transactions in this position.

Does Sarah Ketterer still hold G?

Yes, Sarah Ketterer continues to hold GENPACT LTD (G). According to their 2026 Q1 report, they maintain a position of 1,948,677 shares valued at approximately $72.59M, representing 0.89% of their equity portfolio.

When did Sarah Ketterer first invest in G?

Sarah Ketterer first invested in GENPACT LTD (G) in 2020 Q2 at the reported quarter-end price of $36.52 per share, acquiring 1,204,671 shares in their initial purchase.

What is Sarah Ketterer's average cost basis for G?

Based on historical transaction data, Sarah Ketterer's estimated cost basis for GENPACT LTD (G) is approximately $40.92 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$40.92
Weighted AVG sell price:
$42.27

G transactions history by Causeway Capital Management

24 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q1
0.89%
1,948,677
$37.25
$72,588,251
-6.50% (-135,532)
-0.07%
2025 Q4
1.34%
2,084,209
$46.78
$97,499,333
+10.95% (+205,777)
+0.13%
2025 Q3
1.04%
1,878,432
$41.89
$78,687,453
+31.25% (+447,261)
+0.25%
2025 Q2
1.00%
1,431,171
$44.01
$62,985,812
+51.50% (+486,511)
+0.34%
2025 Q1
0.99%
944,660
$50.38
$47,591,992
-16.84% (-191,358)
-0.22%
2024 Q4
1.11%
1,136,018
$42.95
$48,791,994
-35.20% (-617,154)
-0.65%
2024 Q3
1.69%
1,753,172
$39.21
$68,741,848
-16.53% (-347,097)
-0.37%
2024 Q2
1.84%
2,100,269
$32.19
$67,607,645
+5.23% (+104,380)
+0.09%
2024 Q1
1.72%
1,995,889
$32.97
$65,798,259
-16.23% (-386,728)
-0.32%
2023 Q4
2.11%
2,382,617
$34.71
$82,700,568
+10.35% (+223,407)
+0.2%
2023 Q3
2.06%
$36.20
+7.18% (+144,611)
2023 Q2
1.99%
$37.57
+36.37% (+537,248)
2023 Q1
1.64%
$46.22
+0.70% (+10,211)
2022 Q4
1.97%
$46.32
-31.36% (-670,341)
2022 Q3
2.62%
$43.77
-19.55% (-519,427)
2022 Q2
2.81%
$42.36
-2.71% (-73,884)
2022 Q1
2.84%
$43.51
+11.67% (+285,296)
2021 Q4
2.85%
$53.08
+17.77% (+368,947)
2021 Q3
2.22%
$47.51
-3.49% (-75,025)
2021 Q2
2.00%
$45.43
-0.23% (-4,873)
2021 Q1
1.82%
$42.82
+59.44% (+803,966)
2020 Q4
1.05%
$41.36
+29.94% (+311,597)
2020 Q3
0.75%
$38.95
-13.60% (-163,787)
2020 Q2
0.79%
$36.52
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.